Company intelligence / Profile preview

Ohalo Genetics

Ownership: Private
Employees: ~15
Development stage: Commercial

Overview

Ohalo Genetics has developed a proprietary "Boosted Breeding" technology that enables both parent plants to pass their entire genomes to offspring via clonal gametes. This allows for the rapid development of new plant varieties with all desired parental traits—improving yield, quality, disease resistance, and climate adaptability. The company is developing several novel crop varieties including a potato with reduced sugar content but has not yet reported commercial sales or large-scale field results.

Modalities: Molecular breedingGene editingQuantitative genetics
Industry: Agriculture & AgTech

Partnerships

Not specifically disclosed as of June 2025.

Beyond the preview

Go deeper on Ohalo Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ohalo Genetics.

Explore the full profile